# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Timestamp:** 2026-01-30T10:39:01.773276
**Response ID:** resp_07ee906e2d5431f600697c5f9db9388196badc1fc15bce882e
**Tokens:** 10030 in / 5950 out
**Response SHA256:** 2ab4dbaa9d7a3017

---

## 1) DATA–DESIGN ALIGNMENT (critical)

- **Treatment timing vs. data coverage:** Your stated data window is **2014–2024** (QCEW), and the latest treated cohort is **2023 (Utah)**. This satisfies **max(treatment year)=2023 ≤ max(data year)=2024**. No mismatch.
- **Post-treatment observations by cohort:** Every treated cohort listed has at least some post-treatment support:
  - 2015 adopters: post years 2015–2024 (10)
  - 2017 adopter: 2017–2024 (8)
  - 2021 adopters: 2021–2024 (4)
  - 2022 adopters: 2022–2024 (3)
  - 2023 adopter: 2023–2024 (2)
  No cohort is “treated” without post-treatment data.
- **Treatment definition consistency:** Table 1 cohort years match Table 6, and the text consistently defines \(D_{st}=1[t \ge G_s]\) including the adoption year. No internal timing contradiction detected.

## 2) REGRESSION SANITY (critical)

Checked all reported quantitative results (Tables 3–5, 7; cohort estimates; robustness estimates):

- **No implausible coefficient magnitudes** for a log outcome (all estimates are on the order of a few percentage points; nothing near |10|, nothing remotely near |100|).
- **No implausible standard errors** (none enormous; none > 100×|coef|; none negative; no obvious collinearity blow-ups).
- **No impossible statistics** shown (no negative SEs, no NA/NaN/Inf, no invalid R² reported).

## 3) COMPLETENESS (critical)

- **No placeholders** (no “TBD/TODO/XXX/NA” cells in the tables you show).
- **Regression tables report N and standard errors** (Table 3 includes Observations/States and SEs; Tables 4–5 include SEs and sample sizes; Table 7 includes SEs and a joint test p-value).
- **Figures/tables referenced appear to exist in the draft excerpt** (e.g., Figure 1, Tables 1–7, Table 6).

## 4) INTERNAL CONSISTENCY (critical)

- **Abstract ↔ Table 3 match:** \(-0.0185\) with p-value reported as 0.09 is consistent with the stated “1.9 percent reduction” and “not significant at conventional levels.”
- **Cohort heterogeneity claims ↔ Table 4 match:** 2017 cohort negative and significant; 2023 Utah positive and significant; described as limited post period—consistent with Table 1/4.
- **Sample arithmetic is consistent:** 31 states × 11 years = 341 state-years, matching Table 3 and Table 2 totals (88 + 253 = 341).

ADVISOR VERDICT: PASS